The longevity testing market has never been bigger. Full-body MRIs. Epigenetic age clocks. DEXA scans. Continuous glucose monitors. Advanced blood panels. Wearables tracking every heartbeat and sleep cycle. You could spend $10,000 a year on diagnostic testing — and still not know the single most important number for predicting how long you’ll live.
With so many options, figuring out the best tests for longevity can feel overwhelming. Most of these tools generate data. Far fewer actually predict health outcomes. This guide ranks them by evidence, explains what each one measures and misses, and shows why VO2 Max — measured through clinical breath analysis — belongs at the top of the list.
Tier 1: The Single Best Test for Longevity
Cardio-Metabolic Breath Testing (CPET)
What it measures: VO2 Max, resting metabolic rate, fat oxidation rate, metabolic flexibility, ventilatory thresholds, respiratory exchange ratio, and 20+ additional biomarkers across four physiological systems — heart, lungs, cells, and nervous system.
Why it matters: The American Heart Association’s 2016 scientific statement — updated in 2024 — concluded that cardiorespiratory fitness, measured as VO2 Max, should be treated as a clinical vital sign. The evidence is overwhelming: low CRF is associated with higher all-cause mortality, cardiovascular disease, and cancer mortality at rates equal to or exceeding those of smoking, hypertension, and diabetes.
A JAMA meta-analysis of 33 studies found that each 1-MET improvement in CRF reduced all-cause mortality by 13% and cardiovascular mortality by 15%. No other single test produces a biomarker with that predictive power — which is why breath testing consistently ranks as one of the best tests for longevity in evidence-based practice.
But VO2 Max is only part of what breath testing reveals. The respiratory exchange ratio (RER) — the balance of oxygen consumed to carbon dioxide produced — is a direct window into mitochondrial health. A resting RER that skews toward carbohydrate dependence signals metabolic inflexibility and potential insulin resistance, even in people whose blood glucose looks normal.
Fat oxidation rate shows how efficiently mitochondria burn fat for fuel. RMR reveals baseline energy production — and when it declines, it’s an early signal of muscle loss, metabolic adaptation, or mitochondrial dysfunction. These are the most sensitive metabolic markers available, and they change before body composition, blood work, or wearable data shift.
How often to test: Every 3–6 months. More frequently during active interventions (GLP-1 therapy, training program changes, menopause transition, post-illness recovery). For anyone building a longevity testing routine, this is the anchor — the test everything else builds around.
What it can’t do: Cannot detect structural abnormalities, tumors, or organ damage. Does not measure hormone levels, nutrient status, or genetic markers.
Tier 2: Tests That Complete the Picture
No single test covers everything. The best approach to longevity testing combines functional measurement with biochemical and structural data. These Tier 2 tests fill the gaps that breath testing can’t.
Blood Panels (Standard and Advanced)
What they measure: Hormone levels, lipid profiles, glucose, HbA1c, inflammatory markers (CRP, IL-6), thyroid function, nutrient status (vitamin D, B12, iron, magnesium), metabolic panels.
Why they matter: Blood work provides the biochemical layer. It reveals what’s circulating — hormone imbalances, insulin resistance markers, inflammation, and nutrient deficiencies that affect metabolic function. Advanced panels like apolipoprotein B, Lp(a), and fasting insulin add precision to cardiovascular risk assessment.
Limitations: Blood panels capture a static snapshot. They don’t tell you how efficiently those circulating hormones and nutrients are being used at the cellular level. A person can have normal glucose and still have poor metabolic flexibility. Normal testosterone and still have declining RMR from muscle loss. Blood work is essential — but on its own, it’s not among the best tests for longevity because it maps the chemistry without measuring the machinery.
How often to test: Annually for baseline panels. Every 6 months during active protocols or clinical monitoring.
DEXA Scan (Body Composition)
What it measures: Bone mineral density, lean mass, fat mass, visceral adipose tissue — with regional precision.
Why it matters: DEXA is the gold standard for body composition analysis. For GLP-1 users, menopausal women, and anyone losing weight, it answers the critical question: are you losing fat or muscle? It also detects early osteopenia/osteoporosis — a significant concern for postmenopausal women and anyone on long-term caloric restriction.
Limitations: DEXA measures mass, not function. You can have adequate lean mass and still have a dangerously low VO2 Max. You can have a favorable body composition and still have poor fat oxidation and metabolic inflexibility. DEXA shows what you’re made of. Breath testing shows how well it works.
How often to test: Every 6–12 months.
Full-Body MRI
What it measures: Detailed structural imaging of organs, tissues, bones, and blood vessels. Can detect tumors, aneurysms, cysts, fatty liver, and other abnormalities.
Why it matters: Structural imaging catches hidden pathology early. Life-saving catches — early-stage cancers, brain aneurysms, kidney tumors — are real and documented.
Limitations: No major medical association recommends full-body MRI for asymptomatic adults. False positives are common — published data suggests a 16% prevalence of false-positive findings in asymptomatic populations. Cost is high ($500–$2,500+ per scan). And critically, structural imaging cannot assess functional health: cardiovascular fitness, metabolic rate, fat oxidation, or mitochondrial efficiency.
How often to test: Consult with a physician. For those pursuing it proactively, most longevity physicians recommend no more than annually. Biennial may be more appropriate for asymptomatic adults.
Tier 3: Tests That Track — But Don’t Diagnose
These tools have their place, but they sit in a different category when evaluating the best tests for longevity. They track trends and generate awareness — but they don’t measure the functional markers that predict health outcomes.
Wearables (Apple Watch, WHOOP, Oura, Garmin)
What they measure: Heart rate, HRV, sleep stages, step count, resting heart rate trends, estimated VO2 Max (some devices), respiratory rate.
Why they matter: Wearables provide continuous, longitudinal data. They’re excellent for tracking trends — sleep consistency, HRV recovery, daily activity levels. They create accountability and awareness.
Limitations: Wearables estimate — they don’t measure. VO2 Max estimates from wrist-based devices use heart rate algorithms that can produce errors significant enough to misclassify fitness levels entirely. They cannot measure RMR, fat oxidation, metabolic flexibility, or respiratory exchange ratio. Wearables are great companions, but when choosing the best tests for longevity, clinical-grade measurement always wins over consumer-grade estimation.
Continuous Glucose Monitors (CGMs)
What they measure: Real-time interstitial glucose fluctuations in response to food, exercise, stress, and sleep.
Why they matter: CGMs offer valuable insight into glycemic variability and post-meal glucose spikes. For diabetics and pre-diabetics, they’re clinically essential. For healthy individuals, they can reveal hidden glucose intolerance.
Limitations: Glucose is one metabolic variable among many. A CGM can’t tell you your VO2 Max, your fat oxidation rate, or your metabolic flexibility — which is actually a more comprehensive proxy for insulin sensitivity than glucose tracking alone. CGMs measure one input to the metabolic system. Breath testing measures the system’s total output.
Epigenetic Age Testing (TruDiagnostic, Elysium)
What they measure: DNA methylation patterns used to estimate biological age via epigenetic clocks (Horvath, GrimAge, PhenoAge, DunedinPACE).
Why they matter: Epigenetic clocks provide a molecular snapshot of biological aging. Research has established correlations between accelerated epigenetic aging and increased disease risk and mortality.
Limitations: Epigenetic age is a research-grade tool, not a clinical diagnostic. Results can vary between testing companies and clock algorithms. Most importantly, an epigenetic clock gives you a number but not the levers. It tells you “you’re aging faster” — it can’t tell you whether the driver is low cardiovascular fitness, poor fat oxidation, insulin resistance, or muscle loss. That’s why, when ranking the best tests for longevity by actionability, breath testing identifies the specific functional markers that drive biological aging — giving you something to act on, not just a number to worry about.
How to Build Your Longevity Testing Stack
Not everyone needs every test. Here’s a practical framework ranked by impact:
Essential (start here): Cardio-metabolic breath testing — VO2 Max, RMR, fat oxidation, metabolic flexibility. This is the foundation. It measures the functional system that predicts longevity most powerfully and provides the actionable data to change it.
Strongly recommended: Annual blood panels (standard + advanced cardiovascular markers) and DEXA scan for body composition baseline — especially if you’re over 40, on GLP-1 therapy, or navigating menopause.
Valuable additions: Wearables for continuous daily tracking. CGM for a 2–4 week glucose deep dive if metabolic syndrome or insulin resistance is suspected.
Optional (for those who want the full picture): Full-body MRI for structural screening. Epigenetic age testing for a molecular aging baseline. These are useful additions, but they don’t change the foundation — the best tests for longevity are the ones that measure how your body performs, not just what it looks like inside.
The key principle: test function first. Structure and biomarkers fill in the gaps. But when it comes to choosing the best tests for longevity, the system that determines how long and how well you live is metabolic — and it’s measurable in a single breath test.
The Bottom Line: Among the Best Tests for Longevity, VO2 Max Stands Alone
The longevity testing market will continue to grow. New tools will emerge. But the hierarchy of evidence hasn’t changed: among all available tests for longevity, cardiorespiratory fitness — measured as VO2 Max through clinical breath analysis — is the strongest predictor of all-cause mortality in medicine today. The American Heart Association says it should be a vital sign. The ACSM says it should be assessed in every clinical setting. The JAMA meta-analysis puts a number on it: 13% lower mortality for every 1-MET you gain.
Everything else is additive. VO2 Max is foundational.
SOURCES
- AHA Scientific Statement — Ross et al., “Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign” (Circulation, 2016): https://pubmed.ncbi.nlm.nih.gov/27881567/
- Update to AHA CRF Statement — Kaminsky et al., (Progress in Cardiovascular Diseases, 2024): https://pubmed.ncbi.nlm.nih.gov/38387825/
- JAMA — Kodama et al., “Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events” (2009): https://pubmed.ncbi.nlm.nih.gov/19454641/
- ACSM — “The Importance of Cardiorespiratory Fitness, A 10-Year Update” (2025): https://acsm.org/cardiorespiratory-fitness-10-year-update/
- ScienceDirect — “Assessing CRF in clinical and community settings: 100th year anniversary of VO2max” (2024): https://www.sciencedirect.com/science/article/abs/pii/S0033062024000306
- Time — “A Full-Body MRI Scan Could Save Your Life. Or Ruin It.” (March 2026): https://time.com/7275819/should-you-get-full-body-mri-scan/
- Journal of Magnetic Resonance Imaging — “Incidental findings in asymptomatic individuals undergoing full-body MRI: prevalence and significance” (2019 meta-analysis of 12 studies, 5,000+ participants — 16% false-positive prevalence): Referenced in Fortune coverage: https://www.fortune.com/well/article/prenuvo-full-body-mri-scan-benefits-drawbacks
- American College of Radiology — Statement on full-body CT/MRI screening (2023): Referenced in Time coverage.
Related Posts
Full-Body MRI vs. Metabolic Testing: What Each Reveals (and What It Misses)
Peptides for Menopause: What the Evidence Actually Supports (and What It Doesn’t)
